Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsJason Kwah, MD, MSc
Assistant Professor AdjunctAbout
Research
Publications
2026
Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study
Lommatzsch M, Schmidt O, Timmermann H, Gappa M, Watz H, Kwah J, Ledanois O, Nischan N, Hahn M, Heimann A, Korn S. Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study. Respiratory Medicine 2026, 254: 108750. PMID: 41785977, DOI: 10.1016/j.rmed.2026.108750.Peer-Reviewed Original ResearchConceptsEffects of dupilumab treatmentAsthma Control Test scoreDupilumab treatmentSevere asthmaLong-term effectsClinical efficacyLong-term dupilumab treatmentPre-bronchodilator forced expiratory volumeInterim analysisLung functionQuality of lifeAsthma Control Questionnaire scoreClinical asthma remissionAsthma controlEfficacy of dupilumabClinical remission rateAssociated with sustained improvementFractional exhaled nitric oxideMonths of treatmentQuestionnaire overall scoreExhaled Nitric OxideReal-world patientsSerum immunoglobulin EPost-baseline assessmentRandomized Controlled TrialsValidity of PEN-FAST as a clinical decision tool in pregnant patients
You L, Belmont A, Liao J, Su C, Trubiano J, Son M, Burn M, Kwah J. Validity of PEN-FAST as a clinical decision tool in pregnant patients. Journal Of Allergy And Clinical Immunology Global 2026, 5: 100671. PMID: 41852857, PMCID: PMC12993893, DOI: 10.1016/j.jacig.2026.100671.Peer-Reviewed Original ResearchPregnant patientsPenicillin allergyOral challengeGestational ageSkin testLow riskPredictive valueNegative predicative valueNegative predictive valuePenicillin allergy testingAssociated with adverse patient outcomesSevere adverse eventsNegative likelihood ratioArea under the curvePositive predictive valueClinical decision toolClinical decision-making toolImmunology clinicRisk stratificationAdverse eventsAllergy evaluationAllergy testingAdverse patient outcomesPatientsPatient outcomesComparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study
Bourdin A, Canonica G, Virchow J, Borsos K, Stanford R, Ledanois O, Kwah J, Ge W, Huynh L, Duh M, Boca A, Cheng W, Gandhi A. Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. Respiratory Research 2026, 27: 67. PMID: 41639827, PMCID: PMC12903220, DOI: 10.1186/s12931-026-03515-7.Peer-Reviewed Original ResearchLung function improvementInverse probability of treatment weightingPost-index periodSevere asthmaReal-world studyFunctional improvementBaseline characteristicsRetrospective chart review studyDupilumab-treated patientsPost-BD FEV1Inverse probabilityTreated with omalizumabProbability of treatment weightingChart review studyLinear regressionResidual confoundingEffectiveness of biologicsComparative effectiveness dataClinical trialsTreatment weightingExpiratory volumePatientsPpFEV1Biologic initiationClinical practice
2025
High-Risk Penicillin Reaction Flags in the Medical Record
Novotny S, Elmansy L, Kwah J, Liao J, Wong K, Stone C, Belmont A. High-Risk Penicillin Reaction Flags in the Medical Record. JAMA Network Open 2025, 8: e2549081. PMID: 41632130, PMCID: PMC12717615, DOI: 10.1001/jamanetworkopen.2025.49081.Peer-Reviewed Original Research
2024
Improving cefazolin administration for surgical prophylaxis in reported penicillin allergy: A retrospective study of a health system intervention
Belmont A, Son M, Hyman J, You L, Su C, Kashyap N, Topal J, McManus D, Martinello R, Kwah J. Improving cefazolin administration for surgical prophylaxis in reported penicillin allergy: A retrospective study of a health system intervention. Journal Of Allergy And Clinical Immunology Global 2024, 4: 100377. PMID: 39830990, PMCID: PMC11742594, DOI: 10.1016/j.jacig.2024.100377.Peer-Reviewed Original ResearchPenicillin allergy labelHospital-wide guidelinesSurgical site infectionAllergy labelsSurgical patientsSevere allergic reactionsSurgical prophylaxisSite infectionAssociated with increased rates of surgical site infectionRate of surgical site infectionMulti-drug resistant infectionsAllergic reactionsPrevent surgical site infectionsFirst-line antibioticsFirst-line prophylaxisAdministration of cefazolinAssociated with increased ratesRetrospective cohort studyGuideline-directed therapyAdult surgical patientsPre-intervention groupPost-intervention groupPenicillin allergyPerioperative outcomesCefazolin administrationDiagnosis and clinical management of drug allergies in obstetrics and gynecology: an expert review
Burn M, Kwah J, Son M. Diagnosis and clinical management of drug allergies in obstetrics and gynecology: an expert review. American Journal Of Obstetrics And Gynecology 2024, 232: 243-261. PMID: 39490659, DOI: 10.1016/j.ajog.2024.10.025.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPenicillin allergyAntibiotic allergyAllergy evaluationDrug allergySkin testOral challengePregnant patientsObstetrician-GynecologistsAntibiotic useAssociated with increased cesarean deliveryAllergy testingGroup B streptococcus sepsisPatient historyNeonatal length of stayManagement of drug allergyIncreased length of hospital stayUnverified penicillin allergyLength of hospital stayFirst-line therapyFirst line antibioticsInduction of drug toleranceHigh-risk patientsSurgical site infectionIncreased surgical site infectionAdministration of antibioticsThe Cost of Developing and Implementing an Antepartum Referral Program for Penicillin Allergy Evaluation at a Single Academic Tertiary Care Hospital
Burn M, Xu X, Kwah J, Liao J, Son M. The Cost of Developing and Implementing an Antepartum Referral Program for Penicillin Allergy Evaluation at a Single Academic Tertiary Care Hospital. American Journal Of Perinatology 2024, 41: 1290-1297. PMID: 38423122, DOI: 10.1055/a-2278-9279.Peer-Reviewed Original ResearchCost of careReferral programLong-term cost benefitsPenicillin allergyAntibiotic costsAntibiotic stewardshipPregnant individualsProgram developmentAcademic tertiary care hospitalCompare costs of carePenicillin allergy evaluationShort-term costsTertiary care hospitalDelivery hospitalizationsResource utilization dataNo significant differenceNonreferred patientsCare hospitalUtilization dataAllergy evaluationBivariate testsStudy groupEducational initiativesPregnancy periodProgram costs
2023
Evaluating the PEN-FAST Clinical Decision-making Tool to Enhance Penicillin Allergy Delabeling
Su C, Belmont A, Liao J, Kuster J, Trubiano J, Kwah J. Evaluating the PEN-FAST Clinical Decision-making Tool to Enhance Penicillin Allergy Delabeling. JAMA Internal Medicine 2023, 183: 883-885. PMID: 37338869, PMCID: PMC10282954, DOI: 10.1001/jamainternmed.2023.1572.Peer-Reviewed Original ResearchDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. Journal Of The American Academy Of Dermatology 2023, 90: 911-926. PMID: 37516356, DOI: 10.1016/j.jaad.2023.02.073.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSevere cutaneous adverse reactionsCutaneous adverse reactionsSystemic symptomsDrug reactionsAdverse reactionsDifferential diagnosisDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromeDiHS/DRESSVisceral organ involvementSteroid-sparing agentCornerstone of managementFirst-line therapyEvidence-based overviewSystemic corticosteroidsHypersensitivity syndromeImmediate discontinuationOrgan involvementRisk stratificationAutoimmune diseasesAdjunctive testNeoplastic disordersDiagnostic criteriaLongitudinal evaluationDiagnosisDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. Journal Of The American Academy Of Dermatology 2023, 90: 885-908. PMID: 37516359, DOI: 10.1016/j.jaad.2023.02.072.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSevere cutaneous adverse reactionsDiHS/DRESSClinicopathological featuresSystemic symptomsDrug reactionsDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromePart I. EpidemiologyVisceral organ involvementCutaneous adverse reactionsRisk of relapseHypersensitivity syndromeOrgan involvementI. EpidemiologyOrgan dysfunctionSignificant morbidityAutoimmune diseasesAdverse reactionsDrug exposureT cellsCommon triggerImmune systemPathogenesisEosinophiliaMedical education activities
Academic Achievements & Community Involvement
News
News
- September 03, 2025
Yale Researchers Uncover Biological Differences in Asthma Between Males and Females
- December 14, 2023
Solving the Drug Allergy Puzzle: A Q&A With Ami Belmont
- October 12, 2023
Welcome New Staff, Faculty, Postdocs & Postgrads! (October 2023)
- April 17, 2023
Yale Allergy & Immunology Presents at AAAAI
Get In Touch
Contacts
Email